98%| A1457022|Formula:C30H48O3|Molecular Weight:456.700350000+ products instock " />

成人免费xx,国产又黄又湿又刺激不卡网站,成人性视频app菠萝网站,色天天天天

Home Cart Sign in  
Chemical Structure| 472-15-1 Chemical Structure| 472-15-1

Structure of Betulinic acid
CAS No.: 472-15-1

Chemical Structure| 472-15-1

*Storage: {[sel_prStorage]}

*Shipping: {[sel_prShipping]}

{[proInfo.proName]}

CAS No.: 472-15-1

,{[proInfo.pro_purity]}

Betulinic acid is a natural pentacyclic triterpene compound that inhibits eukaryotic topoisomerase I with an IC50 of 5 μM and exhibits anti-inflammatory, antimalarial, anti-HIV, and antitumor activities.

Synonyms: Lupatic acid; Betulic acid; Mairin

4.5 *For Research Use Only !

{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]} Purity: {[proInfo.pro_purity]}

Change View

Size Price VIP Price

US Stock

Global Stock

In Stock
{[ item.pr_size ]} Inquiry {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate,item.pr_is_large_size_no_price, item.vip_usd) ]}

US Stock: ship in 0-1 business day
Global Stock: ship in 2 weeks

  • {[ item.pr_size ]}

In Stock

- +

Please Login or Create an Account to: See VIP prices and availability

US Stock: ship in 0-1 business day
Global Stock: ship in 2 weeks

  • 1-2 Day Shipping
  • High Quality
  • Technical Support
Product Citations

Alternative Products

Product Details of Betulinic acid

CAS No. :472-15-1
Formula : C30H48O3
M.W : 456.70
SMILES Code : C[C@@]1([C@@]2(CC[C@]3(C(C)([C@H](CC[C@@]3([C@]2(CC[C@@]1([C@]4([C@@H](CC5)C(C)=C)[H])[H])[H])C)O)C)[H])C)CC[C@]45C(O)=O
Synonyms :
Lupatic acid; Betulic acid; Mairin
MDL No. :MFCD00009619
InChI Key :QGJZLNKBHJESQX-FZFNOLFKSA-N
Pubchem ID :64971

Safety of Betulinic acid

GHS Pictogram:
Signal Word:Warning
Hazard Statements:H315-H319-H335
Precautionary Statements:P261-P305+P351+P338

Related Pathways of Betulinic acid

pyroptosis

Isoform Comparison

Biological Activity

Target
  • Topo I

    Eukaryotic topoisomerase I, IC50:5 μM

In Vitro:

Cell Line
Concentration Treated Time Description References
HT22 cells 12 μg/mL BA showed no significant toxicity to HT22 cells PMC8781388
PANC-1 cells 5, 10, 20 μM 12, 24, 48 hours To assess the direct cytotoxicity of BA, which showed concentration- and time-dependent inhibition of cell proliferation. PMC3245664
FG cells 2.5, 5, 10 μM 48 hours To evaluate the cytotoxic effects of BA and MIT alone or in combination, showing inhibition of cell proliferation. PMC3245664
BxPC-3 cells 5, 10, 20 μM 12, 24, 48 hours To assess the direct cytotoxicity of BA, which showed concentration- and time-dependent inhibition of cell proliferation. PMC3245664
A172 cells 0, 3, 6, 12, 24, 48 μg/mL 24 hours BA NPs significantly inhibited A172 cell proliferation with IC50 of 8.5 μg/mL PMC8781388
U87 cells 0, 3, 6, 12, 24, 48 μg/mL 24 hours BA NPs significantly inhibited U87 cell proliferation with IC50 of 12.1 μg/mL PMC8781388
PANC-1 cells 50 μM 48 hours Gene expression profiles were analyzed by cDNA microarray after BA treatment, revealing significant downregulation of lamin B1. PMC3800003

Clinical Trial:

NCT Number Conditions Phases Recruitment Completion Date Locations
NCT00346502 Dysplastic Nevus Syndrome Phase 1 Phase 2 Suspended(The study has been t... More >>emporarily suspended due to funding issues) Less << December 2015 United States, Illinois ... More >> University of Illinois at Chicago Medical Center Chicago, Illinois, United States, 60612 Less <<
NCT00701987 Melanoma PHASE1 UNKNOWN - Robert H. Lurie Comprehensive ... More >>Cancer Center, Northwestern University, Chicago, Illinois, 60611, United States Less <<

Protocol

Bio Calculators
Preparing Stock Solutions 1mg 5mg 10mg

1 mM

5 mM

10 mM

2.19mL

0.44mL

0.22mL

10.95mL

2.19mL

1.09mL

21.90mL

4.38mL

2.19mL

References

[1]Melzig MF, Bormann H. Betulinic acid inhibits aminopeptidase N activity. Planta Med. 1998 Oct;64(7):655-7.

[2]Fujioka T, Kashiwada Y, et al. Anti-AIDS agents, 11. Betulinic acid and platanic acid as anti-HIV principles from Syzigium claviflorum, and the anti-HIV activity of structurally related triterpenoids. J Nat Prod. 1994 Feb;57(2):243-7.

[3]Chowdhury AR, Mandal S, Mittra B, Sharma S, Mukhopadhyay S, Majumder HK. Betulinic acid, a potent inhibitor of eukaryotic topoisomerase I: identification of the inhibitory step, the major functional group responsible and development of more potent derivatives. Med Sci Monit. 2002 Jul;8(7):BR254-65. PMID: 12118187.

[4]Kasperczyk H, La Ferla-Brühl K, Westhoff MA, Behrend L, Zwacka RM, Debatin KM, Fulda S. Betulinic acid as new activator of NF-kappaB: molecular mechanisms and implications for cancer therapy. Oncogene. 2005 Oct 20;24(46):6945-56. doi: 10.1038/sj.onc.1208842. PMID: 16007147.

[5]Gao Y, Ma Q, Ma YB, Ding L, Xu XL, Wei DF, Wei L, Zhang JW. Betulinic acid induces apoptosis and ultrastructural changes in MDA-MB-231 breast cancer cells. Ultrastruct Pathol. 2018 Jan-Feb;42(1):49-54. doi: 10.1080/01913123.2017.1383548. Epub 2017 Dec 1. PMID: 29192840.

[6]Hashimoto F, Kashiwada Y, Cosentino LM, Chen CH, Garrett PE, Lee KH. Anti-AIDS agents--XXVII. Synthesis and anti-HIV activity of betulinic acid and dihydrobetulinic acid derivatives. Bioorg Med Chem. 1997 Dec;5(12):2133-43. doi: 10.1016/s0968-0896(97)00158-2. PMID: 9459011.

[7]Kalra J, Lingaraju MC, Mathesh K, Kumar D, Parida S, Singh TU, Sharma AK, Kumar D, Tandan SK. Betulinic acid alleviates dextran sulfate sodium-induced colitis and visceral pain in mice. Naunyn Schmiedebergs Arch Pharmacol. 2018 Mar;391(3):285-297. doi: 10.1007/s00210-017-1455-3. Epub 2017 Dec 26. PMID: 29279966.

 

Historical Records

Categories